Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Short-term Investments (2018 - 2025)

Historic Short-term Investments for Lexaria Bioscience (LEXX) over the last 8 years, with Q4 2025 value amounting to $143267.0.

  • Lexaria Bioscience's Short-term Investments rose 25929.03% to $143267.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $143267.0, marking a year-over-year increase of 25929.03%. This contributed to the annual value of $143267.0 for FY2025, which is 15671.87% up from last year.
  • Latest data reveals that Lexaria Bioscience reported Short-term Investments of $143267.0 as of Q4 2025, which was up 25929.03% from $143267.0 recorded in Q3 2025.
  • In the past 5 years, Lexaria Bioscience's Short-term Investments registered a high of $833841.0 during Q3 2021, and its lowest value of $33540.0 during Q2 2025.
  • Its 5-year average for Short-term Investments is $250752.1, with a median of $205485.5 in 2023.
  • Its Short-term Investments has fluctuated over the past 5 years, first soared by 421572.38% in 2021, then tumbled by 8282.13% in 2024.
  • Over the past 5 years, Lexaria Bioscience's Short-term Investments (Quarter) stood at $493424.0 in 2021, then plummeted by 45.34% to $269707.0 in 2022, then crashed by 73.15% to $72427.0 in 2023, then tumbled by 44.94% to $39875.0 in 2024, then soared by 259.29% to $143267.0 in 2025.
  • Its Short-term Investments was $143267.0 in Q4 2025, compared to $143267.0 in Q3 2025 and $33540.0 in Q2 2025.